Survey Among Healthcare Professionals and MS Patients to Assess Their Understanding of RMP Materials

Novartis

Status: Completed

Conditions: Multiple Sclerosis

Study type: Observational

Funder types: Industry

Identifiers

NCT05301907

EUPAS44782 (Other Identifier)

CBAF312A2006

Details and patient eligibility

About

Survey to be completed independently by HCPs (neurologists treating patients with MS and MS specialist nurses) and patients/caregivers.

Full description

The survey- based study was conducting amongst HCPs and patients/caregivers in selected European countries including Germany, Netherlands, Nordics (Denmark, Sweden), Spain and Croatia, plus Canada, to evaluate whether HCPs and patients/caregivers receive the educational materials and to capture their knowledge of specific Mayzent (siponimod) safety measures.

Enrollment: 335 patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Physicians were considered eligible for the survey if they meet the following screening criteria:

• Care for relapsing MS (RMS) patients
• Personally prescribed disease modifying therapies to MS patients, and;
• Have prescribed Mayzent (siponimod) in at least 1 SPMS patient.

Nurses were considered eligible for the survey if they:

• Provide supportive care for RMS patients
• Have initiated and/or managed the use of Mayzent (siponimod) in at least 1 SPMS patient.

Patient inclusion criteria include:

- Had initiated onto Mayzent (siponimod) to treat their MS since reimbursement

Exclusion criteria

-

Trial design

335 participants in 2 patient groups

Health Care Professionals (HCPs)

Description:

HCPs who prescribe, monitor and oversee the management / or provide in person medical supervision of patients on Mayzent (siponimod).

Patients/Caregivers

Description:

Patients/Caregivers of patients who are taking Mayzent (siponimod) to treat their MS and according to the prescription of their neurologists across EU countries and Canada that were included in the launch program